Ventilator-associated tracheobronchitis: an update

Area of Science:

• Critical Care Medicine
• Infectious Diseases
• Respiratory Medicine

Background:

• Ventilator-associated lower respiratory tract infection is a common complication in mechanically ventilated patients.
• Ventilator-associated tracheobronchitis was historically considered benign and not requiring antibiotic treatment.
• Recent research suggests tracheobronchitis may precede ventilator-associated pneumonia.

Purpose of the Study:

• To evaluate the clinical significance and impact of ventilator-associated tracheobronchitis.
• To assess the association of ventilator-associated tracheobronchitis with patient outcomes and healthcare resource utilization.
• To highlight the importance of including ventilator-associated tracheobronchitis in clinical management and surveillance.

Main Methods:

• Literature review and analysis of existing studies on ventilator-associated tracheobronchitis.
• Examination of epidemiological data and clinical management strategies.
• Assessment of the impact on mortality, length of stay, antibiotic use, and mechanical ventilation duration.

Main Results:

• Ventilator-associated tracheobronchitis has a minimal impact on overall mortality.
• Significant associations found with increased patient costs, prolonged hospital stays, and extended mechanical ventilation.
• Increased antibiotic use is also linked to ventilator-associated tracheobronchitis.

Conclusions:

• Ventilator-associated tracheobronchitis, despite low mortality impact, has significant economic and clinical consequences.
• Management and surveillance strategies should incorporate this condition.
• Further research is needed to clarify optimal treatment modalities.